Serial Number:
97121020
Mark:
NKMAX
Status:
Registered
Status Date:
08-22-2023
Filing Date:
Registration Number:
7146622
Registration Date:
08-22-2023
Pharmaceutical preparations for animals for regulating the immune system and treating cancer; pharmaceutical preparations, namely, immunomodulators; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of cells for regulating the immune system and treating cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biopharmaceutical products for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; stem cells for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of immune system related diseases and disorders Development of cell therapy products; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes; medical and pharmacological research services; medical research services; development of biotechnology products; biotechnological research; cell separation research services; technological research in the field of cell therapy, medicine, pharmacology, biotechnology
Mark Description:
N/A
Class:
Scientific and technological services
Type of Mark:
Trademark
Published for Opposition Date:
10-25-2022
Owner:
Mark Drawing Status:
Standart Character Mark
Abandon Date:
N/A
Business Name:
PEARNE & GORDON LLP
Correspondent Name: